VERU INC. Variable Lease, Cost
VERU INC. (VERU) reported Variable Lease, Cost of $17.91 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-10
- VERU INC. variable lease, cost for the quarter ending 2026-06-30 was $17.91K, a 229.21% increase year-over-year.
- VERU INC. variable lease, cost for the quarter ending 2026-03-31 was $46.34K, a 1.93% decline year-over-year.
- VERU INC. variable lease, cost for the quarter ending 2025-12-31 was $5.34K, a 305.46% increase year-over-year.
- VERU INC. variable lease, cost for the quarter ending 2025-09-30 was $5.34K, a 305.46% increase year-over-year.
- VERU INC. variable lease, cost for fiscal 2025 was $59.35K, a 203.12% increase from fiscal 2024.
- VERU INC. variable lease, cost for fiscal 2024 was $19.58K, a 89.52% decline from fiscal 2023.
- VERU INC. variable lease, cost for fiscal 2023 was $186.90K, a 11.77% decline from fiscal 2022.
- VERU INC. variable lease, cost for fiscal 2022 was $211.84K, a 18.66% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.91K 10-Q · filed 2026-08-10 | $64.25K derived: sum of 2 quarters · filed 2026-08-10 | $69.59K 10-Q · filed 2026-08-10 | $74.94K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $46.34K 10-Q · filed 2026-05-13 | $51.68K 10-Q · filed 2026-05-13 | $57.03K derived: sum of 3 quarters · filed 2026-05-13 | $62.47K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $5.34K 10-Q · filed 2026-02-11 | $10.69K derived: sum of 2 quarters · filed 2026-02-11 | $16.13K derived: sum of 3 quarters · filed 2026-08-10 | $63.38K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-09-30 | $5.34K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $10.78K derived: sum of 2 quarters · filed 2026-08-10 | $58.03K derived: sum of 3 quarters · filed 2026-08-10 | $59.35K 10-K · filed 2025-12-17 | ||||
| 2025-06-30 | $5.44K 10-Q · filed 2026-08-10 | $52.69K derived: sum of 2 quarters · filed 2026-08-10 | $54.01K 10-Q · filed 2026-08-10 | $55.33K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $47.25K 10-Q · filed 2026-05-13 | $48.57K 10-Q · filed 2026-05-13 | $49.89K derived: sum of 3 quarters · filed 2026-05-13 | $51.20K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $1.32K 10-Q · filed 2026-02-11 | $2.64K derived: sum of 2 quarters · filed 2026-02-11 | $3.95K derived: sum of 3 quarters · filed 2026-02-11 | $6.93K derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-09-30 | $1.32K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $2.64K derived: sum of 2 quarters · filed 2025-12-17 | $5.62K derived: sum of 3 quarters · filed 2025-12-17 | $19.58K 10-K · filed 2025-12-17 | $79.07K 10-K · filed 2024-12-16 | |||
| 2024-06-30 | $1.32K 10-Q · filed 2025-08-12 | $14.84K 10-Q · filed 2024-08-08 | $4.30K derived: sum of 2 quarters · filed 2025-08-12 | $18.26K 10-Q · filed 2025-08-12 | $58.64K 10-Q · filed 2024-08-08 | $68.60K derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $2.98K 10-Q · filed 2025-05-08 | $15.30K 10-Q · filed 2024-05-08 | $16.95K 10-Q · filed 2025-05-08 | $43.80K 10-Q · filed 2024-05-08 | $67.28K derived: sum of 3 quarters · filed 2025-05-08 | $101.21K derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $13.96K 10-Q · filed 2025-02-13 | $28.50K 10-Q · filed 2024-04-01 | $64.30K derived: sum of 2 quarters · filed 2025-02-13 | $98.23K derived: sum of 3 quarters · filed 2025-02-13 | $150.78K derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-09-30 | $50.34K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-16 | $84.26K derived: sum of 2 quarters · filed 2024-12-16 | $136.81K derived: sum of 3 quarters · filed 2024-12-16 | $186.90K 10-K · filed 2024-12-16 | ||||
| 2023-06-30 | $33.93K 10-Q · filed 2024-08-08 | $86.48K derived: sum of 2 quarters · filed 2024-08-08 | $136.57K 10-Q · filed 2024-08-08 | $186.12K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $52.55K 10-Q · filed 2024-05-08 | $102.64K 10-Q · filed 2024-05-08 | $152.20K derived: sum of 3 quarters · filed 2024-05-08 | $221.73K derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $50.09K 10-Q · filed 2024-04-01 | $99.64K derived: sum of 2 quarters · filed 2024-04-01 | $169.18K derived: sum of 3 quarters · filed 2024-04-01 | $215.91K derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-09-30 | $49.55K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | $119.08K derived: sum of 2 quarters · filed 2024-04-01 | $165.82K derived: sum of 3 quarters · filed 2024-04-01 | $211.84K 10-K/A · filed 2024-04-01 | ||||
| 2022-06-30 | $69.53K 10-Q/A · filed 2023-11-15 | $116.27K derived: sum of 2 quarters · filed 2023-11-15 | $162.29K 10-Q/A · filed 2023-11-15 | $216.53K derived: sum of 4 quarters · filed 2023-11-15 | ||||
| 2022-03-31 | $46.74K 10-Q · filed 2023-05-11 | $92.76K 10-Q · filed 2023-05-11 | $147.00K derived: sum of 3 quarters · filed 2023-05-11 | $195.06K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $46.02K 10-Q · filed 2023-02-09 | $100.26K derived: sum of 2 quarters · filed 2023-02-09 | $148.32K derived: sum of 3 quarters · filed 2023-02-09 | $187.86K derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-09-30 | $54.24K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05 | $102.31K derived: sum of 2 quarters · filed 2022-12-05 | $141.84K derived: sum of 3 quarters · filed 2022-12-05 | $178.53K 10-K · filed 2022-12-05 | ||||
| 2021-06-30 | $48.06K 10-Q · filed 2022-08-11 | $87.60K derived: sum of 2 quarters · filed 2022-08-11 | $124.28K 10-Q · filed 2022-08-11 | $186.79K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $39.54K 10-Q · filed 2022-05-12 | $76.22K 10-Q · filed 2022-05-12 | $138.72K derived: sum of 3 quarters · filed 2022-05-12 | $162.94K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $36.68K 10-Q · filed 2022-02-09 | $99.19K derived: sum of 2 quarters · filed 2022-02-09 | $123.40K derived: sum of 3 quarters · filed 2022-02-09 | $157.07K derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-09-30 | $62.50K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-02 | $86.72K derived: sum of 2 quarters · filed 2021-12-02 | $120.39K derived: sum of 3 quarters · filed 2021-12-02 | $153.85K 10-K · filed 2021-12-02 | ||||
| 2020-06-30 | $24.21K 10-Q · filed 2021-08-12 | $57.88K derived: sum of 2 quarters · filed 2021-08-12 | $91.35K 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | $33.67K 10-Q · filed 2021-05-12 | $67.14K 10-Q · filed 2021-05-12 | ||||||
| 2019-12-31 | $33.47K 10-Q · filed 2021-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |